HK1017669A1 - Novel tricyclic compounds and drug compositions containing the same - Google Patents

Novel tricyclic compounds and drug compositions containing the same

Info

Publication number
HK1017669A1
HK1017669A1 HK99102818A HK99102818A HK1017669A1 HK 1017669 A1 HK1017669 A1 HK 1017669A1 HK 99102818 A HK99102818 A HK 99102818A HK 99102818 A HK99102818 A HK 99102818A HK 1017669 A1 HK1017669 A1 HK 1017669A1
Authority
HK
Hong Kong
Prior art keywords
represents hydrogen
same
amino
compositions containing
tricyclic compounds
Prior art date
Application number
HK99102818A
Other languages
English (en)
Inventor
Shiro Miyoshi
Kohei Ogawa
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Publication of HK1017669A1 publication Critical patent/HK1017669A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04—Diamides of sulfuric acids
    • C07C307/10—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76—Dibenzothiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK99102818A 1996-01-10 1999-07-05 Novel tricyclic compounds and drug compositions containing the same HK1017669A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP257696 1996-01-10
PCT/JP1996/003689 WO1997025311A1 (fr) 1996-01-10 1996-12-18 Nouveaux composes tricycliques et compositions medicamenteuses contenant ces composes

Publications (1)

Publication Number Publication Date
HK1017669A1 true HK1017669A1 (en) 1999-11-26

Family

ID=11533209

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99102818A HK1017669A1 (en) 1996-01-10 1999-07-05 Novel tricyclic compounds and drug compositions containing the same

Country Status (14)

Country Link
US (4) US6037362A (fr)
EP (1) EP0882707B1 (fr)
JP (1) JP2000239255A (fr)
KR (1) KR100395280B1 (fr)
CN (2) CN1083831C (fr)
AT (1) ATE251608T1 (fr)
AU (1) AU715233B2 (fr)
CA (1) CA2242351C (fr)
DE (1) DE69630319T2 (fr)
ES (1) ES2208772T3 (fr)
HK (1) HK1017669A1 (fr)
NO (2) NO312159B1 (fr)
PT (1) PT882707E (fr)
WO (1) WO1997025311A1 (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025355A (en) * 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6040344A (en) * 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
PT938467E (pt) * 1996-11-11 2002-11-29 Sepracor Inc Processo para a preparacao de isomeros opticamente puros de formoterol
ES2149742T1 (es) 1997-07-03 2000-11-16 Asahi Chemical Ind Nuevos compuestos triciclicos que tienen anillos saturados y composiciones medicinales que contienen los mismos.
WO1999051564A1 (fr) * 1998-04-06 1999-10-14 Fujisawa Pharmaceutical Co., Ltd. Derives de propanolamine
US20030073644A1 (en) * 1998-11-11 2003-04-17 Smithkline Beecham P.L.C. Combinations comprising a beta-agonist and a further antidiabetic agent
EP1128845A1 (fr) * 1998-11-11 2001-09-05 Smithkline Beecham Plc Combinaisons comprenant un beta-agoniste et un autre agent anti-diabetique
AU751833B2 (en) * 1998-12-15 2002-08-29 Asahi Kasei Kabushiki Kaisha Novel heterocyclic compounds and drug compositions containing the same
TW519537B (en) * 1999-03-26 2003-02-01 Asahi Chemical Ind Process for the preparation of tricylic amino-alcohol derivatives
EP1174426A1 (fr) * 1999-04-01 2002-01-23 Asahi Kasei Kabushiki Kaisha Procede de preparation de derives d'alcools amines tricycliques avec des azides
CN1360574A (zh) * 1999-07-09 2002-07-24 旭化成株式会社 制备三环氨基醇衍生物的方法
KR20020030802A (ko) * 1999-09-03 2002-04-25 야마모토 카즈모토 삼환식 아미노 알코올 유도체의 제조 방법
US20030220329A1 (en) * 1999-09-17 2003-11-27 Duke University Method of improving beta-adrenergic receptor function
AU7447900A (en) * 1999-10-04 2001-05-10 Asahi Kasei Kabushiki Kaisha Method for improving the solubility of tricyclic amino alcohol derivatives
WO2001044187A1 (fr) * 1999-12-16 2001-06-21 Asahi Kasei Kabushiki Kaisha Nouveaux composes tricycliques substitues
US20030018061A1 (en) * 2000-01-28 2003-01-23 Kohei Ogawa Novel remedies with the use of beta 3 agonist
CA2407538C (fr) 2000-04-28 2007-01-09 Asahi Kasei Kabushiki Kaisha Nouveaux composes bicycliques
WO2001083453A1 (fr) * 2000-04-28 2001-11-08 Asahi Kasei Kabushiki Kaisha Nouveaux composes tricycliques substitues
WO2001083452A1 (fr) * 2000-04-28 2001-11-08 Asahi Kasei Kabushiki Kaisha Nouveaux composes tricycliques
GB0010757D0 (en) * 2000-05-05 2000-06-28 Astrazeneca Ab Chemical compounds
MXPA03005648A (es) * 2000-12-22 2003-10-06 Astrazeneca Ab Derivados de carbazol y su uso, como ligandos de receptor del neuropeptido y5.
JPWO2002074306A1 (ja) * 2001-03-19 2004-07-08 旭化成ファーマ株式会社 脂肪肝治療薬
GB0121941D0 (en) * 2001-09-11 2001-10-31 Astrazeneca Ab Chemical compounds
KR100816527B1 (ko) * 2001-09-12 2008-04-10 한국화학연구원 페닐테트라졸 유도체로 치환된 β-아미노알코올 화합물
ATE497948T1 (de) 2001-10-25 2011-02-15 Asahi Kasei Pharma Corp Bicyclische verbindungen
WO2003072573A1 (fr) 2002-02-27 2003-09-04 Pfizer Products Inc. Formes cristallines de (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol
US6864268B2 (en) 2002-02-27 2005-03-08 Pfizer Inc. β3 adrenergic receptor agonists
CA2471646A1 (fr) 2002-02-27 2003-09-04 Yong Tao Procedes et intermediaires utiles dans la preparation d'agonistes du recepteur .beta.3-adrenergique
EP1424079A1 (fr) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combinaison d'un agoniste du beta-3-récepteur et d'un inhibiteur de recaptage de sérotonine et/ou norépinéphrine
EP1593666B1 (fr) * 2003-02-14 2008-07-02 Kissei Pharmaceutical Co., Ltd. Derives d'amino-alcools, compositions pharmaceutiques contenant ces derives et utilisation associee
CA2541894A1 (fr) * 2003-10-24 2005-05-06 Kissei Pharmaceutical Co., Ltd. Derive d'amino-alcool, composition pharmaceutique contenant ce dernier, et leur utilisation
US8501994B2 (en) 2007-08-28 2013-08-06 Sunovion Pharmaceuticals Inc. Acetamide stereoisomer
US7718822B2 (en) 2007-08-28 2010-05-18 Sepracor Inc. Carbamate Stereoisomer
CN102171191A (zh) 2008-10-09 2011-08-31 旭化成制药株式会社 吲唑衍生物
AU2009301798B2 (en) 2008-10-09 2012-03-01 Asahi Kasei Pharma Corporation Indazole compound
US20100222404A1 (en) * 2008-11-04 2010-09-02 Asahi Kasei Pharma Corporation Indazole derivative dihydrochloride
EP2484668A4 (fr) * 2009-09-30 2013-03-27 Asahi Kasei Pharma Corp Analogue d'indazole
WO2012032546A2 (fr) * 2010-09-08 2012-03-15 Cadila Healthcare Limited Procédé pour la préparation de salmétérol et de ses produits intermédiaires
ES2394349B1 (es) 2012-08-29 2013-11-04 Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar
WO2014108449A1 (fr) 2013-01-08 2014-07-17 Atrogi Ab Procédé de criblage, trousse, méthode de traitement et composé destinés à être utilisé dans une méthode de traitement
US10478445B2 (en) 2013-07-03 2019-11-19 Georgetown University Boronic acid derivatives of resveratrol for activating deacetylase enzymes
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
CN115656390B (zh) * 2022-12-08 2023-03-28 成都苑东生物制药股份有限公司 一种氨酚羟考酮缓释片的含量测定方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL33573A (en) * 1968-12-30 1973-10-25 Richardson Merrell Inc Bis-basic ethers and thioethers of fluorenone,fluorenol and fluorene
GB1521089A (en) * 1975-11-12 1978-08-09 Valeas Srl Aminoethanol derivatives
FR2332010A1 (fr) * 1975-11-18 1977-06-17 Continental Pharma Amino-alcool heterocyclique, son sel et son procede de preparation
DK31578A (da) * 1977-02-03 1978-08-04 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af benzenderivater
JPS5473751A (en) * 1977-10-12 1979-06-13 Yamanouchi Pharmaceut Co Ltd Phenyl ethanolamine derivatives and their preparation
CA1147342A (fr) * 1977-10-12 1983-05-31 Kazuo Imai Procede de preparation de nouveaux derives de la phenylethanolamine
JPS5553262A (en) * 1978-10-17 1980-04-18 Yamanouchi Pharmaceut Co Ltd Phenylethanolamine derivative
EP0023385B1 (fr) * 1979-06-16 1982-12-15 Beecham Group Plc Dérivés d'éthanamines, leur préparation et leur utilisation dans des compositions pharmaceutiques
JPS5950671B2 (ja) * 1982-08-26 1984-12-10 山之内製薬株式会社 フェニルエタノ−ルアミン誘導体およびその製造法
GB8419797D0 (en) * 1984-08-03 1984-09-05 Beecham Group Plc Compounds
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
CN1129443A (zh) * 1993-06-14 1996-08-21 美国辉瑞有限公司 仲胺用作治糖尿病和治肥胖病药物
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
IL113410A (en) * 1994-04-26 1999-11-30 Merck & Co Inc Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
JPH08165276A (ja) * 1994-12-14 1996-06-25 Dainippon Pharmaceut Co Ltd ２−アルキルアミノ−１−フェニルエタノール誘導体

Also Published As

Publication number Publication date
US6187809B1 (en) 2001-02-13
CA2242351C (fr) 2003-03-11
KR19990077162A (ko) 1999-10-25
EP0882707A1 (fr) 1998-12-09
US6037362A (en) 2000-03-14
DE69630319D1 (de) 2003-11-13
KR100395280B1 (ko) 2004-06-04
JP2000239255A (ja) 2000-09-05
NO312159B1 (no) 2002-04-02
CN1209119A (zh) 1999-02-24
CN1295064A (zh) 2001-05-16
DE69630319T2 (de) 2004-07-29
AU1170897A (en) 1997-08-01
ES2208772T3 (es) 2004-06-16
CA2242351A1 (fr) 1997-07-17
EP0882707A4 (fr) 2001-04-11
NO20012876L (no) 1998-09-10
WO1997025311A1 (fr) 1997-07-17
US20030139475A1 (en) 2003-07-24
NO983197L (no) 1998-09-10
ATE251608T1 (de) 2003-10-15
PT882707E (pt) 2004-02-27
EP0882707B1 (fr) 2003-10-08
AU715233B2 (en) 2000-01-20
US6545053B1 (en) 2003-04-08
CN1083831C (zh) 2002-05-01
NO20012876D0 (no) 2001-06-11

Similar Documents

Publication Publication Date Title
HK1017669A1 (en) Novel tricyclic compounds and drug compositions containing the same
HUT42272A (en) Insecticides containing derivatives of nitro-methilen and process for production of the derivatives of nitromethilen
DE69002248D1 (de) 1,2-cyclohexylaminoarylamide zu verwendung als analgetika.
NZ235323A (en) Amide derivatives and pharmaceutical compositions thereof
HUT70536A (en) Arylsulfonamido-substituted hydroxamic acids, process for preparing them and pharmaceutical compositions containing them
BR8906791A (pt) Composicao inseticida; derivado de guanidina e processo para sua preparacao
EP1006122A4 (fr) Derives de phenylethylamine
ZA9811576B (en) Anilide derivative, production and use thereof.
PL325575A1 (en) Novel n-aryl piperidine compounds, method of obtaining them and pharmaceutic composition containing such compounds
HUT47128A (en) Process for producing oxetanocins and pharmaceutical compositions comprising such compounds
HU9400250D0 (en) Quinoline-or quinazoine derivatives process fop producing them and pharmaceutical compositions containing them
AU5795694A (en) New bicyclic nitrogen compounds, process for preparing them and pharmaceutical compositions containing them
NZ228065A (en) 1,2,4-triazinediones and parasiticidal compositions; processes for preparation
AU672052B2 (en) Antidepressant and antiparkinsonian compounds
AU755654C (en) Novel amide compounds and drugs containing the same
NO894349D0 (no) Tienopyridin-type mevalonolaktoner.
AU3191293A (en) New naphthalene amides and sulphonamides, processes for their preparation and pharmaceutical compositions containing them
HU903197D0 (en) Process for producing 5,11-dihydrodibenzo(b,e) (1,4)-thiazepine derivatives and medicament preparatives containing these compounds
SI0870761T1 (en) Thiocolchicine derivatives with antiinflammatory and muscle relaxant activities
NO960441D0 (no) Benzopyraner og farmasöytiske forbindelser inneholdende dem
ES2149193T3 (es) Compuestos heterociclicos sustituidos con alquilo.
AU3648093A (en) Pyrrolidine derivatives useful as 5-HT3-antagonists
BR9705662A (pt) Piridinas substituìdas.
NZ332245A (en) Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them
TW288012B (fr)

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20051218